Bristol Addresses Serzone/Seroquel Mix-Ups With Patient Information Leaflet
Executive Summary
Bristol-Myers Squibb will distribute Serzone patient information leaflets with each prescription of the anti-depressant, to address medication mix-ups with AstraZeneca's anti-psychotic Seroquel